Vident Advisory’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $449K | Sell |
14,250
-636
| -4% | -$20K | 0.01% | 1121 |
|
|
2025
Q1 | $488K | Buy |
14,886
+494
| +3% | +$16.2K | 0.01% | 1044 |
|
|
2024
Q4 | $520K | Buy |
14,392
+309
| +2% | +$11.2K | 0.01% | 919 |
|
|
2024
Q3 | $439K | Sell |
14,083
-8,793
| -38% | -$274K | 0.01% | 1001 |
|
|
2024
Q2 | $612K | Buy |
22,876
+7,713
| +51% | +$206K | 0.02% | 789 |
|
|
2024
Q1 | $517K | Buy |
15,163
+1,332
| +10% | +$45.4K | 0.01% | 810 |
|
|
2023
Q4 | $400K | Buy |
13,831
+2,879
| +26% | +$83.3K | 0.01% | 880 |
|
|
2023
Q3 | $302K | Buy |
+10,952
| New | +$302K | 0.01% | 900 |
|